Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term open-label extension study of ADV7103 in distal renal tubular acidosis
2013-003828-36Phase 3Completed
- Sponsor
- Advicenne
- Start
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of Sibnayal in distal renal tubular acidosis (dRTA) and renal tubular acidosis (RTA), sponsored by Advicenne. Primary endpoint: Safety and tolerability. Started Aug 2015; status: completed.
02
Drugs
Sibnayal
03
Conditions
distal renal tubular acidosis (dRTA)renal tubular acidosis (RTA)
Beyond the preview
Go deeper on 2013-003828-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003828-36.